Evidence map›Paper›PMID 28413468›Full record

ArticleExperimental and therapeutic medicine2017

Antitumor effect of sunitinib in human prostate cancer cells functions via autophagy.

Bangqi Wang, Dongyuan Lu, Min Xuan, Weilie Hu

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Targeting Lysosomes for Enhanced Anti-Cancer Therapeutics and Immune Response.International journal of biological sciences · 2026
    Review
  2. Dual role of autophagy in bone metastasis: mechanistic insights and therapeutic targeting.American journal of clinical and experimental urology · 2025
    Review
  3. Article
  4. Unveiling the Molecular Landscape ofInternational journal of molecular sciences · 2023
    Article
  5. Review
  6. Review
  7. Guanabenz Sensitizes Glioblastoma Cells to Sunitinib by Inhibiting GADD34-Mediated Autophagic Signaling.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Bangqi WangSouthern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Dongyuan LuGraduate School of The Second Military Medical University, Shanghai 200433, P.R. China.
Min XuanDepartment of Plastic Surgery, General Hospital of Guangzhou Military Command, Guangzhou, Guangdong 510010, P.R. China.
Weilie HuDepartment of Urology, General Hospital of Guangzhou Military Command, Guangzhou, Guangdong 510010, P.R. China.
General Hospital of Guangzhou Military Command · CNSecond Military Medical University · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to explore sunitinib-induced autophagic effects and the specific molecular mechanisms involved,

Indexed as

apoptosisautophagyextracellular signal-regulated kinases 1/2mechanistic target of rapamycinprostate cancer cellssunitinib

Identifiers

PMID28413468
PMCPMC5377283
OpenAlexW2589390011

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.